Associate Director, Medical Communications and Publications, Solid Tumors

Associate Director, Medical Communications And Publications, Solid Tumors

At Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

At Genmab, we're committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose. The Associate Director of Medical Communications will be responsible for driving the medical communications and publications strategy and activities for assigned Solid tumor asset(s). The individual will play an integral role in leading strategy development, planning, and execution of high-quality scientific publications. This role will collaborate with other functions and departments, including Clinical Development, Clinical Operations, Market Access, Biostatistics, Commercial, Corporate Communications, Translational & Quantitative Sciences and external collaborators to implement the medical communications strategy. Functioning as a member of the Global Medical Affairs department, this individual will report to the Senior Director of Medical Communications and Publications. We have a hybrid model, and onsite presence is required 60% (3 days / week) of the time in Plainsboro, NJ.

Responsibilities

• Lead the development, implementation, and execution of a global medical communication plan including abstracts, posters, oral presentations, and manuscripts
• In development and execution of a strategic publication plan, the individual will 1) drive the strategic publication planning meetings 2) collaborate with key global cross-functional stakeholders 3) anticipate risks and identify solutions for publication planning 4) recognize changes in the healthcare and treatment landscape and adjust publication / communication plans in a timely and efficient manner.
• Serve as the subject matter expert on publication-related matters working closely with internal and external disease-area experts to ensure high quality analysis, interpretation, communication, and planning of data disclosures.
• Develop scientific content deliverables (including but not limited to, scientific communication platform, FAQs) and congress content obtaining insights from key stakeholders, ensuring development of materials that are aligned with overall asset and therapeutic area strategy.
• Bring a global perspective and mindset with the ability to work effectively with colleagues and key stakeholders across cultures, backgrounds, and geographies.
• Implement digital enhancements of publications.
• Manage annual budget and work with allocated resources, ensuring contracts, SOWs and invoices are submitted accurately and in a timely manner to ensure high quality deliverables.
• Liaise with agency / vendor partners to ensure timely delivery of quality publication by providing direction, reviewing developed content, and ensuring process is consistent with Genmab SOPs.
• Promote and reinforce good publication practices and principles among authors and internal stakeholders ensuring all medical publications are being authored, written and reviewed according to GPP and Genmab SOPs
• Bring subject matter expertise in discussions regarding the creation or updates to departmental SOPs improving / modifying processes and procedures helping to achieve organizational goals.

Qualifications

For US based candidates, the proposed salary band for this position is as follows : $152,000.00 $228,000.00 The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as bonuses.

Regular full-time U.S. employees are eligible to enroll in Genmab benefits. Our benefits package is crafted to help employees feel supported and cared for in all aspects of life physical, financial, social, and emotional.

About You

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you're in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com.